ストックスクリーナーアプリを入手
33.92
1.65%
-0.57
アフターアワーズ：
33.92
前日終値:
$34.49
開ける：
$33.97
24時間の取引高:
347.08K
Relative Volume:
1.40
時価総額：
$2.83B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.43%
1か月 パフォーマンス:
+13.67%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$33.00
$34.69
1週間の範囲:
$31.01
$36.53
52週間の値動き範囲:
$28.27
$36.68
Heartflow Inc Stock (HTFL) Company Profile
HTFL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HTFL
Heartflow Inc
|
33.92 | 2.88B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
279.93 | 45.56B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
77.33 | 13.76B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
74.38 | 13.91B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
96.16 | 8.12B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.09 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-02 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | JP Morgan | Overweight |
| 2025-09-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-02 | 開始されました | Piper Sandler | Overweight |
| 2025-09-02 | 開始されました | Stifel | Buy |
Heartflow Inc (HTFL) 最新ニュース
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
Why HeartFlow Stock Rocketed 14% Higher Today - Yahoo Finance
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com UK
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Issues Earnings Results, Misses Expectations By $1.26 EPS - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
HeartFlow: Q2 Earnings Snapshot - New Haven Register
HeartFlow, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Heartflow, Inc. SEC 10-Q Report - TradingView
Stocks Generating Improved Relative Strength: Heartflow - MSN
Heartflow Completes US$364 Million Upsized IPO - Global Legal Chronicle
Heartflow, Inc.'s (NASDAQ:HTFL) Quiet Period Will Expire on September 17th - MarketBeat
HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation - TipRanks
Heartflow (NASDAQ:HTFL) Shares Gap UpHere's Why - MarketBeat
HeartFlow Releases Investor Presentation at Healthcare Conference - TipRanks
Heartflow Incexpects Q2 2025 revenue of $43.4 millionSEC filing - MarketScreener
HeartFlow (HTFL): Evaluating Valuation After Recent Share Price Surge Without a Clear Catalyst - Yahoo Finance
Heartflow (NASDAQ:HTFL) Stock Rating Upgraded by Zacks Research - MarketBeat
Med-tech financings hold steady through August, IPOs rebound - BioWorld MedTech
Heartflow, Inc. (NASDAQ:HTFL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Morgan Stanley Initiates Coverage on Heartflow (NASDAQ:HTFL) - MarketBeat
Heartflow (NASDAQ:HTFL) Coverage Initiated at JPMorgan Chase & Co. - MarketBeat
VentriPoint: The Echo Play In AI Cardiac Imaging's Trillion-Dollar Convergence - Barchart.com
Heartflow (NASDAQ:HTFL) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World
Stifel initiates coverage on Heartflow stock with Buy rating, $35 target - Investing.com India
Heartflow, Inc. shares rise 2.70% after-hours following positive analyst ratings from Morgan Stanley and Stifel. - AInvest
Heartflow announces pricing of upsized IPO - MSN
Wall Street analysts initiate AI diagnostic co HeartFlow with bullish views - Investing.com Canada
Morgan Stanley initiates coverage on Heartflow stock with Equalweight rating - Investing.com India
Canaccord Genuity initiates Heartflow stock with Buy rating on AI cardiac tools - Investing.com
Top 5 Stock Initiation Reports for Tuesday: Firefly Aerospace, HeartFlow, WhiteFiber, Tempus AI, and Penumbra - AInvest
Morgan Stanley initiates coverage on Heartflow stock with Equalweight rating By Investing.com - Investing.com Australia
Heartflow Inc (HTFL) 財務データ
Heartflow Inc (HTFL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.09%
1.40%
大文字化:
|
ボリューム (24 時間):